PTH-related peptide (PTHrP) has been implicated in a variety of developmental and homeostatic processes. Although mice homozygous for the targeted disruption of the Pthrp gene have greatly expanded our capacity to investigate the developmental roles of the protein, the perinatal lethality of these animals has severely hindered the analysis of Pthrp's postnatal physiological effects. To overcome this obstacle, we have generated mice homozygous for a floxed Pthrp allele, i.e. two loxP sites flanking exon 4 of the Pthrp gene, which encodes most of the protein, with the aim of accomplishing cell typeand tissue-specific deletion of the gene. The ability of the Cre enzyme to cause recombination between the loxP sites and excision of the intervening DNA sequence was tested in vivo by crossing this strain to mice carrying a cre transgene under the transcriptional control of the human ␤-actin promoter. The ubiquitous deletion of the floxed allele in the cre/loxP progeny resulted in perinatal lethality as a consequence of aberrant endochondral bone formation, fully recapitulating all the phenotypic abnormalities observed in the conventional Pthrp knockout mouse. The availability of the floxed Pthrp mice will serve as a valuable tool in genetic experiments that aim to investigate the physiological actions of Pthrp in the postnatal state. (Endocrinology 142: 2070 -2077, 2001) P TH-related peptide (PTHrP) was initially identified as the humoral factor responsible for hypercalcemia in malignancy. It is now recognized that its spectrum of physiological actions encompasses a wide variety of developmental and homeostatic processes during fetal and adult life (1). Mice homozygous for Pthrp gene ablation are born alive but die soon after birth because of a multitude of skeletal deformities arising as a consequence of diminished proliferation and accelerated differentiation of chondrocytes in the developing endochondral skeleton (2-4). However, the perinatal lethality of the Pthrp-null mice precludes observation of potential postnatal tissue-specific alterations arising in the complete absence of Pthrp. Studies using heterozygous Pthrp-null and rescued Pthrp-null mice have implicated pivotal roles for the protein in bone formation (5), mammary gland development (6), tooth eruption (7), epidermal differentiation (8), and neuronal protection (9) in the postnatal state. Nevertheless, the complexity of the phenotypic alterations associated with these transgenic models makes the interpretation of these findings rather difficult to consolidate. Therefore, to circumvent these limitations, it has become desirable to generate a mouse strain missing both alleles of the Pthrp gene only in a particular cell type. In this context, chondrocyte proliferation and differentiation would be expected to proceed unaltered. It would be predicted that these mice would be viable and amenable for studying tissuespecific biology in the complete absence of Pthrp.
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The technology for producing such a conditional knockout is based on the cre/loxP site-specific recombination system of bacteriophage P1 that infects the bacterium Escherichia coli. Cre recombinase is an enzyme that catalyzes site-specific recombination between 34-bp sequences of phage DNA, termed loxP sites, thereby removing the DNA between them, leaving one loxP site behind (10) . By combining the cre/loxP site-specific recombination system with embryonic stem (ES) cell technology, the capability of achieving conditional gene targeting has greatly expanded. The production of such a conditional knockout requires the generation of two mouse strains. One strain carries the gene of interest flanked by two loxP sites (floxed gene). The second is a conventional transgenic strain in which the Cre recombinase enzyme is expressed in a cell type-or developmental stage-specific manner. Appropriate mating between these two strains results in excision of the floxed DNA in a defined spatial or temporal manner.
In this study, we describe the generation of a mouse line in which loxP sites were introduced in the genome floxing nearly the entire coding region of the Pthrp gene. The capacity to excise the floxed gene in vivo was confirmed by crossing these animals to mice carrying the cre transgene driven by the human ␤-actin promoter. Total body Cre-mediated recombination of the Pthrp gene resulted in a form of lethal chondrodysplasia, the characteristics of which faithfully recapitulated those of the conventional Pthrp knockout mouse.
Materials and Methods

Construction of the targeting vector
For constructing the floxed targeting vector, DNA sequences derived from the ploxPneo-1 plasmid (from A. Nagy, Lunenfeld Institute, Toronto, Canada), the targeting vector pPTHrPTV (2), and pPGKneoNTRtkpA plasmid (from R. Jaenisch, Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA) were used. The ploxPneo-1 plasmid was partially restricted with XbaI, then completely digested with SalI, and ligated either to the 1.2-kb PstI/SacI fragment of the murine Pthrp gene, encompassing exon 4 (plox4), or to the 4.2-kb XbaI/ NsiI fragment derived from the pPGKneoNTRtkpA vector (ploxPGKneoNTRtkpA), encoding the neomycin resistance (neo r ) and herpes simplex virus-thymidine kinase (hsv-tk) selectable genes with the 5Ј nontranslated region (ntr) of encephalomyocarditis virus inserted between them, following treatment of all DNA fragments with Klenow and dNTPs. The plox4 plasmid containing exon 4 was digested with KpnI/ XhoI and the KpnI/XhoI polylinker sequence derived from the pCDNA3 vector was inserted. Following further restriction with XhoI, the 4.2-kb XhoI fragment obtained from the ploxPGKneoNTRtkpA plasmid was ligated, resulting in plasmid plox4/loxPGKneoNTRtkpA. Restriction of this plasmid with NotI provided a DNA fragment encompassing the floxed 1.2-kb PstI/SacI segment of the Pthrp gene followed by the floxed PGKneoNTRtkpA cassette.
To construct the remaining part of the targeting vector, ploxPneo-1 was digested with XhoI, the ends were blunted, and EcoRI linkers were attached. KpnI restriction of the resulting plasmid was followed by ligation of the 3.6-kb EcoRI fragment derived from the pPTHrPTV, composed of the 3Ј-flanking homology sequence, after blunting and addition of KpnI linkers. The 5Ј-flanking sequence of homology was derived as a 3.4-kb XhoI fragment from the pPTHrPTV plasmid and was inserted into the BamHI site of the resulting vector. Restriction of this plasmid with EcoRI released a DNA fragment encompassing both homology sequences, which when ligated to the NotI fragment derived from plasmid plox4/loxPGKneoNTRtkpA, resulted in the final targeting vector, pPTHrPfloxTV.
Generation of the Pthrp floxed mice
The pPTHrPfloxTV plasmid (25 g) was linearized at the unique NotI site and electroporated into R1 ES cells. Thirty-six hours later, selection was initiated with 300 g/ml G418, resistant ES cell clones were isolated, and genomic DNA was prepared. Following restriction with EcoRI and size fractionation on 0.8% agarose gel, the DNA was transferred onto nitrocellulose filters and hybridized with the 1.1-kb BamHI/SacI genomic fragment containing sequences encoding exon 5 of the Pthrp gene. One of the targeted clones underwent a second round of electroporation with 25 g of supercoiled plasmid pBS185 (from A. Nagy, Lunenfeld Institute) containing the cre recombinase gene under the control of human cytomegalovirus promoter/enhancer. After selection in medium containing 2 m ganciclovir for 5 days, clones were picked and expanded. Genomic DNA was prepared and examined for type II deletions by Southern blot analysis.
Appropriately targeted ES cells were microinjected into 3.5-day postcoitus BALB/c blastocysts and then transferred into uteri of 2.5-day postcoitus pseudopregnant CD1 mice. Seventeen days later chimeric animals were born. Extensively chimeric males were mated to BALB/c females and, following germ line transmission, animals heterozygous for the floxed allele were crossed to generate mice homozygous for the targeted allele.
Mouse strains
The Z/AP mice were provided by C. Lobe (Sunnybrook Health Science Center, Toronto, Canada). The human ␤-actin-cre mice were a generous gift from B. Morgan (Harvard University School of Medicine, Boston, MA) and G. R. Martin (University of California, San Francisco, CA).
Histology
All animal studies were conducted in accordance with principles and procedures dictated by the highest standards of humane animal care. Newborn mice were killed, femurs, tibiae, and ribs were removed and fixed in PLP fixative (2% paraformaldehyde containing 0.075 m lysine and 0.01 m sodium periodate solution) for 24 h at 5 C. Samples were in turn decalcified in EDTA-glycerol solution (14.5 g EDTA, 15 ml glycerol, 85 ml distilled water, and solid sodium hydroxide added until a final pH of 7.3 was reached) for 1-2 days at 5 C. Following dehydration in graded alcohol, tissues were embedded in low-melting-point paraffin, and 5-m sections were cut on a rotary microtome and stained with hematoxylin and eosin (H & E).
Preembedding lacZ staining
Preembedding lacZ staining was performed as described, with some modifications (11) . Samples were fixed with PLP fixative overnight at 5 C, washed three times for 30 min in lacZ wash buffer (2 mm MgCl 2 , 0.01% sodium deoxycholate, 0.02% Nonidet-P40 in PBS), and stained in 0.5 mg/ml X-gal, 5 mm potassium ferrocyanide, and 5 mm potassium ferricyanide in lacZ wash buffer at 37 C overnight with shaking while protected from light. Following staining, samples were decalcified, embedded in paraffin, and 5-m sections were cut on a rotary microtome. Tissues were dewaxed, hydrated by passage through graded alcohol series, washed in running water for 3 min, and mounted with Kaiser's glycerol jelly.
Human placental alkaline phosphatase staining
Tissue staining for human placental alkaline phosphatase activity was performed as previously described (12) . Briefly, tissue sections were preincubated in TBS (50 mm Tris-HCl, 150 mm NaCl, 0.01% Tween 20, pH 7.6) at 70Ϫ75 C for 30 min to inactivate endogenous alkaline phosphatase activity. Following overnight incubation in 1% MgCl 2 and 100 mm Tris-maleate buffer (pH 9.2), sections were incubated for an additional 2 h at room temperature in a 100-mm Tris-maleate buffer containing naphthol AS-MX phosphate (0.2 mg/ml, Sigma, St. Louis, MO) dissolved in ethylene glycol monomethyl ether as substrate and Fast Red TR (0.4 mg/ml, Sigma) as stain for the reaction product. After washing with distilled water, the sections were counterstained with Vector methyl green nuclear stain (Vector Laboratories, Inc., Ontario, Canada) and mounted with Kaiser's glycerol jelly.
Pthrp immunohistochemistry
Paraffin sections were stained for Pthrp using the avidin-biotin-peroxidase complex technique. Sections were first treated with 0.5% bovine testicular hyaluronidase (Sigma) for 30 min at 37 C, to increase antibody penetration and access to epitopes. Rabbit antiserum against Pthrp 1-34 peptide was applied to sections overnight at room temperature. As a negative control, the preimmune serum was substituted for the primary antibody. After washing with high salt buffer (50 mm Tris-HCl, 2.5% NaCl, 0.05% Tween 20, pH 7.6) for 10 min at room temperature followed by two 10-min washes with TBS, the sections were incubated with secondary antibody (biotinylated rabbit antigoat IgG; Sigma), washed as before and processed using the Vectastain ABC-AP kit (Vector Laboratories, Inc.). Red pigmentation to demarcate regions of immunostaining was produced by a 10-to 15-min treatment with Fast Red TR/ Naphthol AS-MX phosphate (Sigma, containing 1 mm levamisole as endogenous alkaline phosphatase inhibitor). The sections were then washed with distilled water, counterstained with methyl green, and mounted with Kaiser's glycerol jelly.
Results
Targeting the Pthrp locus
Our strategy for accomplishing cell-type specific targeting centered on the scheme used to generate Pthrp-negative mice (2) in which deletion of 1.2-kb of genomic DNA sequences (PstI/SacI fragment) encompassing exon 4 of the murine Pthrp gene (13) , resulted in a null allele (Fig. 1A) . The expectation was that exon 4, when flanked by loxP sites, would remain fully functional, but following Cre-mediated excision it would recapitulate the Pthrp-null allele. In the design of the targeting vector, the mouse phosphoglycerate kinase promoter was used to drive expression of both the neo r and hsv-tk selectable genes. The ntr was inserted between the two genes so that a bicistronic mRNA will be generated. Because the ntr sequence includes an internal ribosomal entry site (14) , the hsv-tk gene would be translated in a cap-independent manner.
Following electroporation of the targeting vector and G418 selection, a homologous recombination event introduced the neo r -ntr-hsv-tk genes cassette and three loxP sites into the Pthrp locus, as schematically depicted in Fig. 1A . G418-resistant ES cell clones (276 clones) were isolated and genomic DNA was prepared and examined by Southern blot analysis following restriction with EcoRI and hybridization with probe A, a 1.1-kb BamHI/SacI genomic fragment 3Ј to the targeted homologous region and encompassing exon 5 of the murine Pthrp locus (2). In the case of a targeted recombination event, the wild-type allele would be expected to yield a more than 20-kb fragment, whereas the floxed allele would result in an 11-kb fragment. Two clones having undergone the expected homologous recombination event were identified and subjected to further restriction mapping and Southern blot analysis to confirm the fidelity of the targeting event using either an internal probe (probe B) corresponding to a 382-bp AvrII/SmaI genomic fragment encoding for part of exon 4 (13) or an approximately 600-bp PCR-amplified fragment encompassing exon 3 of the Pthrp gene (probe C), located 5Ј to the targeted homologous region (Fig. 1A) . In addition, the blots were stripped and rehybridized with the r probe, to verify that only a single copy homologous integration event had occurred with no evidence of random integration (data not shown).
One of the two targeted clones was expanded and the ES cells underwent a second round of electroporation with 25 g supercoiled pBS185 plasmid containing the cre recombinase gene under the control of human CMV promoter/enhancer. The loss of the neo r -ntr-hsv-tk genes cassette following excision by Cre recombinase activity, was expected to make the ES cells ganciclovir resistant. After selection in medium containing ganciclovir, 135 surviving clones were picked and expanded. Genomic DNA was again prepared and examined for type II deletions ( Fig. 1B ; floxed exon 4 of Pthrp gene) by Southern blot analysis following digestion with BamHI and hybridization with probe B. The presence of a 5.2-kb band (type II recombination) in conjunction with a 6.2-kb fragment (wild-type allele) in 5 of these clones confirmed the successful removal of the selection genes cassette, while leaving the floxed exon 4 of Pthrp intact. The presence of the 9.5-kb mutant band along with the 6.2-kb wild-type band in several clones indicated that selection with ganciclovir was not particularly effective, perhaps due to low or no expression of the hsv-tk gene.
Generating the floxed Pthrp mice
ES cells from one of these appropriately targeted clones were microinjected into 3.5-day BALB/c blastocysts and chimeric male mice were used to generate animals heterozygous for the floxed Pthrp gene (Pthrp ϩ/flox ; ϩ and flox signify the presence of the wild-type and floxed alleles, respectively). Offspring with this genotype were identified by Southern blot analysis of tail genomic DNA and intercrossed to obtain mice homozygous for the altered allele (Pthrp flox/flox ; Fig. 1C ). As expected, these animals were viable, fertile, and their overall development appeared normal, indicative that the introduction of loxP sites does not interfere with or alter to any significant extent Pthrp gene expression in vivo.
Analysis of Cre function in ␤-actin-cre mice
Next, we wanted to determine whether Cre-mediated excision of the floxed Pthrp allele could be successfully accomplished in vivo. Total-body deletion of the Pthrp gene was to be achieved using a mouse strain carrying a transgene where cre was placed under the transcriptional control of regulatory elements from the human ␤-actin gene (cre actin ), including the promoter, 5Ј enhancer and intron, 3Ј-flanking untranslated region, and polyadenylation sequences (15) . The cre actin transgene was expected to be expressed in all cell lineages of the early embryo. As a first step, we set out to verify the in vivo efficacy of the ␤-actin promoter to drive the ubiquitous and functional expression of Cre by crossing the cre actin mice to the double reporter transgenic line Z/AP mice (11) . The latter strain expresses ubiquitously the lacZ reporter gene under control of the CMV enhancer and chicken ␤-actin promoter before Cre-mediated excision takes place. However, when it does occur, the lacZ gene that is floxed is removed, permitting expression of the second reporter, the human placental alkaline phosphatase gene (hPLAP), only in tissues that express Cre recombinase. In this study, we sought to obtain offspring of the genotype Z/AP;cre actin , as determined by lack of lacZ but presence of hPLAP staining of tail tips. Figure 2 shows stained sections from soft tissues and humeri from a Z/AP mouse as well as from a Z/AP;cre actin littermate. In the absence of cre actin , tissues failed to stain for alkaline phosphatase but stained intensely for lacZ activity, except for chondrocytes and adipocytes, as was reported initially (11) . However, in the presence of the transgene, tissues stained intensely for alkaline phosphatase activity, including chondrocytes and adipocytes, consistent with the ubiquitous and complete excision of the floxed lacZ gene. Therefore, we concluded that the cre gene in the cre actin mouse line functions efficiently to excise floxed DNA segments in all cell lineages.
Generation of a Pthrp-null allele by Cre-mediated recombination
Initially, we chose to target the floxed Pthrp gene in mice of the genotype Pthrp Ϫ/flox (Ϫ indicates the null allele where exon 4 of Pthrp has been replaced with the neo r cassette gene). This was chosen in an attempt to facilitate the excisitional activity of Cre, because in this mouse line every single cell would have only one functional floxed Pthrp allele, the removal of which would result in compound heterozygosity for the null allele (Fig. 3A) . It was anticipated that these animals would recapitulate the phenotypic changes observed in the conventional knockout mouse (2) . Therefore, we crossed mice carrying the cre actin transgene to Pthrp mice to obtain progeny of the genotype Pthrp ϩ/Ϫ ;cre actin . Matings of these animals with mice homozygous for the floxed allele (Pthrp flox/flox ) resulted in the generation of progeny with the desired genotype, Pthrp Ϫ/flox ;cre actin (Fig. 3 , B and C). These animals died in the perinatal period from respiratory failure and exhibited all the phenotypic abnormalities observed in the original Pthrp-null mice. As depicted in Fig. 3D , Pthrp Ϫ/flox ;cre actin mice had the characteristic chondrodystrophic features of domed skull, shortened mandible resulting in protrusion of the tongue, narrow thorax, protuberant abdomen, and shortened long bones. Skeletal preparations stained with alcian blue (cartilage) and alizarin red S (calcified tissue) confirmed the inappropriate and premature ossification throughout the endochondral skeleton, and the anticipated deformities that arise as a consequence of the complete absence of Pthrp (data not shown). Histologic examination of long bones from these animals validated the anticipated growth plate abnormalities such as decreased size in the zone of proliferation, disorganization of chondrocyte columns, and premature differentiantion of chondro- cytes to the hypertrophic state (Figs. 4, A-F, and 5, A-F) . Moreover, immunohistochemical staining of mutant growth plates for Pthrp failed to detect expression of the protein in chondrocytes (Fig. 6, A-D) . These findings established that the floxed Pthrp allele was accessible to Cre-mediated excision in vivo. Subsequently, these studies were repeated with mice of the Pthrp flox/flox ;cre actin genotype, and identical results were obtained, indicating that Cre-mediated excision was equally effective in removing two copies of the floxed allele.
Discussion
In this study, we describe the generation of a mouse line that carries two Pthrp alleles flanked by loxP sites. The demonstration that the floxed sequence can be effectively excised in vivo and thereby reproduce the phenotypic alterations described in the original Pthrp-null fetuses, makes this animal model a valuable resource for now examining tissuespecific Pthrp gene function in the postnatal state. Such studies would otherwise not be possible in view of the perinatal lethality of the conventional null mutant homozygotes.
The advent of gene targeting in ES cells has, over the last decade, revolutionized the in vivo study of gene function and has contributed enormously to our understanding of factors that modulate an ever-increasing number of physiological processes. Yet, as is often the case, early lethality of the mutant strain, an outcome exemplified by the Pthrp knockout mouse, or complex phenotypes preclude such studies at later stages of life or in specific tissues. These limitations have led to the development of a new generation of tools for controlling gene expression in vivo that aim to circumvent such problems associated with the conventional knockout technology. By combining the cre/loxP site-specific recombination with the homologous recombination technology, it has become possible to introduce genomic alterations that are restricting both spatially and temporally (16, 17) .
Despite these advances, a number of potential drawbacks have become apparent with the advent of this novel technique. First, the ability to achieve tissue-specific gene deletion depends on the availability of cre transgenic mice that posses an exquisite degree of specificity and fidelity and achieve high levels in cre expression. Satisfactory tissuespecific restriction is achieved when Cre expression in these transgenic lines is under the transcriptional regulation of the appropriate tissue-specific promoter. On the other hand, nonspecific or low expression can severely confound interpretation of the resultant phenotype. Sorting out promoter specificity and activity has necessitated the generation of reporter mouse lines, like the Z/AP mouse, that provide a precise and accurate assay for Cre-mediated excisional activity at the cellular level (11, 18, 19) . Although the Z/AP transgene was shown to be widely expressed in our studies, no lacZ expression was observed in chondrocytes and adipocytes, as originally reported (11) . However, after Cre excision, both cell types stained intensely for hPLAP activity, suggesting that this discrepancy arises likely from possible sensitivity differences between the lacZ and the hPLAP reporters. In support of this conclusion is the profound alterations in the chondrocyte differentiation program observed in our loxP/cre progeny, confirming that Cre excisional activity had indeed taken place in these cells. Hence, the binary reporter system of the Z/AP transgene helps discriminate between lack of reporter expression and a lack of Cre excision.
The cre actin mice used in the present study were particularly ideal for driving expression of the Cre protein ubiquitously, as required for achieving a total-body deletion of the Pthrp gene. In crosses using these mice, recombination of the target gene in the loxP/cre progeny has been reported to occur in every cell by the 64-cell stage of embryogenesis (15) . The fact that Cre is expressed very early in development, leads to complete recombination in all cells of the embryo, as demonstrated in our studies following crosses of the cre actin mice to the Z/AP reporter strain. This makes the cre actin mice a very efficient line for generating progeny that carry the recombined form of the floxed allele.
Second, the resultant phenotype may be rather complex if deletion of the floxed gene is incomplete. This was a problem associated mainly with earlier studies that made use of the wild-type cre gene of P1 phage (20) . The Cre recombinase expressed from the human ␤-actin-cre transgene used in this study was exceptionally efficient in excising the floxed allele. This degree of efficiency arose from two modifications introduced in the cre gene: first, the sequences surrounding the ATG translation initiation codon matched those reported to be optimal for translation initiation in eukaryotic cells (21) , and second, the coding sequence for the seven-amino acid nuclear localization signal of the large T antigen of SV40 had been introduced into the amino-terminal region of the cre open reading frame (22) .
These potential limitations notwithstanding, studies are now underway aiming to target the floxed Pthrp allele in a tissue-specific fashion. Crossing the Pthrp flox/flox strain to mice exclusively expressing Cre in a variety of cell types will facilitate the functional analysis of Pthrp's role in the postnatal state. Findings arising from such studies will undoubtedly provide us with otherwise unobtainable information about potential actions of Pthrp in adult bone homeostasis, mammary gland, prostate and pancreatic islet cell function, blood pressure control and vascular responsiveness, and neuronal protection from apoptotic cell death.
